Coronary stent thrombosis: what have we learned?
作者信息
Collet Carlos, Sotomi Yohei, Cavalcante Rafael, Suwannasom Pannipa, Tenekecioglu Erhan, Onuma Yoshinobu, Serruys Patrick W
机构信息
Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands ;
Erasmus MC, Rotterdam, The Netherlands ;
出版信息
J Thorac Dis. 2016 Jul;8(7):1398-405. doi: 10.21037/jtd.2016.05.69.
Abstract
摘要
相似文献
1
Coronary stent thrombosis: what have we learned?冠状动脉支架血栓形成：我们学到了什么？
J Thorac Dis. 2016 Jul;8(7):1398-405. doi: 10.21037/jtd.2016.05.69.
2
The Varying Behavior of Stent Thrombosis in Native Coronary Arteries Versus Aorto-Coronary Saphenous Vein Bypass Grafts.冠状动脉原位与主动脉-冠状动脉大隐静脉旁路移植术中支架内血栓形成的不同表现
J Invasive Cardiol. 1997 Jul;9(6):407-409.
3
Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin.噻氯匹定与阿司匹林治疗患者冠状动脉支架血栓形成的时间
Am J Cardiol. 1999 Apr 1;83(7):1006-11. doi: 10.1016/s0002-9149(99)00005-3.
4
The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents.接受裸金属支架和药物洗脱支架治疗的急性冠状动脉综合征患者发生支架内血栓形成的风险。
JACC Cardiovasc Interv. 2009 Jun;2(6):534-41. doi: 10.1016/j.jcin.2009.04.003.
5
Circadian variation in coronary stent thrombosis.冠状动脉支架血栓形成的昼夜节律变化。
JACC Cardiovasc Interv. 2011 Feb;4(2):183-90. doi: 10.1016/j.jcin.2010.09.025.
6
Clinical usefulness of red cell distribution width to angiographic severity and coronary stent thrombosis.红细胞分布宽度对血管造影严重程度和冠状动脉支架血栓形成的临床实用性。
Int J Gen Med. 2016 Sep 9;9:319-24. doi: 10.2147/IJGM.S109452. eCollection 2016.
7
Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.氯吡格雷治疗的急性冠脉综合征患者中，治疗后二磷酸腺苷诱导的血小板聚集及血管扩张剂刺激磷蛋白指数对支架内血栓形成的预测价值
Am J Cardiol. 2009 Oct 15;104(8):1078-82. doi: 10.1016/j.amjcard.2009.06.007.
8
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.在TRITON-TIMI 38试验中，对接受经皮冠状动脉介入治疗和支架置入术的急性冠状动脉综合征患者进行强化口服抗血小板治疗以降低缺血事件（包括支架血栓形成）：一项随机试验的亚分析
Lancet. 2008 Apr 19;371(9621):1353-63. doi: 10.1016/S0140-6736(08)60422-5. Epub 2008 Apr 2.
9
Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications.药物洗脱支架与冠状动脉血栓形成：生物学机制及临床意义
Circulation. 2007 Feb 27;115(8):1051-8. doi: 10.1161/CIRCULATIONAHA.106.675934.
10
Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry.当代冠状动脉支架血栓形成的发生率及相关因素：一项单中心注册研究分析
J Am Coll Cardiol. 2002 Nov 6;40(9):1567-72. doi: 10.1016/s0735-1097(02)02374-4.
引用本文的文献
1
Postmortem diagnosis of coronary subacute stent thrombosis.冠状动脉亚急性支架内血栓形成的尸检诊断
Arch Cardiol Mex. 2024;94(1):95-96. doi: 10.24875/ACM.23000057.
2
In Vivo Efficacy of an Adhesive Bioresorbable Patch to Treat Aortic Dissections.一种用于治疗主动脉夹层的可生物吸收黏附贴片的体内疗效
JACC Basic Transl Sci. 2023 Oct 11;9(1):65-77. doi: 10.1016/j.jacbts.2023.08.002. eCollection 2024 Jan.
3
Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial.超出生物等效性范围测试P2Y12血小板抑制剂仿制药：一项平行单盲随机试验。
Thromb J. 2022 Aug 17;20(1):44. doi: 10.1186/s12959-022-00405-y.
4
Factors Impacting Stent Thrombosis in Patients With Percutaneous Coronary Intervention and Coronary Stenting: A Systematic Review and Meta-Analysis.经皮冠状动脉介入治疗和冠状动脉支架置入患者支架内血栓形成的影响因素：一项系统评价和荟萃分析。
Cureus. 2022 Apr 9;14(4):e23973. doi: 10.7759/cureus.23973. eCollection 2022 Apr.
5
Relationship between atherogenic index of plasma and stent thrombosis in patients with acute coronary syndrome.血浆致动脉粥样硬化指数与急性冠状动脉综合征患者支架血栓形成的关系。
Anatol J Cardiol. 2022 Feb;26(2):112-117. doi: 10.5152/AnatolJCardiol.2021.193.
6
Scaffold underexpansion and late lumen loss after bioresorbable scaffold implantation: Insights from ABSORB JAPAN trial.生物可吸收支架植入后支架扩张不足和晚期管腔丢失：来自ABSORB日本试验的见解。
Int J Cardiol Heart Vasc. 2020 Sep 4;31:100623. doi: 10.1016/j.ijcha.2020.100623. eCollection 2020 Dec.
7
The role of intracoronary imaging in acute coronary syndromes: OCT in focus.冠状动脉内成像在急性冠状动脉综合征中的作用：聚焦光学相干断层扫描
Glob Cardiol Sci Pract. 2016 Dec 30;2016(4):e201636. doi: 10.21542/gcsp.2016.36.
本文引用的文献
1
Incidence and Clinical Outcomes of Stent Fractures on the Basis of 6,555 Patients and 16,482 Drug-Eluting Stents From 4 Centers.基于 4 家中心的 6555 名患者和 16482 枚药物洗脱支架的支架断裂发生率和临床结局。
JACC Cardiovasc Interv. 2016 Jun 13;9(11):1115-23. doi: 10.1016/j.jcin.2016.02.025. Epub 2016 Mar 18.
2
Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography.光学相干断层成像术评估极晚期药物洗脱支架血栓形成的机制。
Circulation. 2016 Feb 16;133(7):650-60. doi: 10.1161/CIRCULATIONAHA.115.019071. Epub 2016 Jan 13.
3
Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry.光学相干断层成像术分析支架内血栓形成的机制：来自法国全国 PESTO 登记研究的见解。
Eur Heart J. 2016 Apr 14;37(15):1208-16. doi: 10.1093/eurheartj/ehv711. Epub 2016 Jan 12.
4
Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model.在猪分流模型中体外评估耐久性聚合物依维莫司洗脱支架相对于具有生物可降解聚合物涂层的当代药物洗脱支架的急性血栓形成性。
JACC Cardiovasc Interv. 2015 Aug 17;8(9):1248-1260. doi: 10.1016/j.jcin.2015.03.029.
5
Incidence and Clinical Significance of Poststent Optical Coherence Tomography Findings: One-Year Follow-Up Study From a Multicenter Registry.支架置入后光学相干断层扫描结果的发生率和临床意义：一项多中心注册研究的一年随访。
Circulation. 2015 Sep 15;132(11):1020-9. doi: 10.1161/CIRCULATIONAHA.114.014704. Epub 2015 Jul 10.
6
Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis.药物洗脱支架和裸金属支架的长期安全性：来自综合网络荟萃分析的证据。
J Am Coll Cardiol. 2015 Jun 16;65(23):2496-507. doi: 10.1016/j.jacc.2015.04.017.
7
Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment.血管新生动脉硬化：组织病理学发现概述及其对血管内影像学评估的影响。
Eur Heart J. 2015 Aug 21;36(32):2147-59. doi: 10.1093/eurheartj/ehv205. Epub 2015 May 20.
8
Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial.新型生物可吸收聚合物涂层依维莫司洗脱冠状动脉支架的疗效与安全性：EVOLVE II随机试验
Circ Cardiovasc Interv. 2015 Apr;8(4). doi: 10.1161/CIRCINTERVENTIONS.114.002372.
9
Suboptimal stent deployment is associated with subacute stent thrombosis: optical coherence tomography insights from a multicenter matched study. From the CLI Foundation investigators: the CLI-THRO study.支架植入不理想与亚急性支架血栓形成相关：一项多中心配对研究的光学相干断层扫描见解。CLI基金会研究人员：CLI-THRO研究。
Am Heart J. 2015 Feb;169(2):249-56. doi: 10.1016/j.ahj.2014.11.012. Epub 2014 Nov 20.
10
Stent thrombosis: a clinical perspective.支架血栓形成：临床观点。
JACC Cardiovasc Interv. 2014 Oct;7(10):1081-92. doi: 10.1016/j.jcin.2014.05.016.
Zotero 插件